{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T17:14:56Z","timestamp":1768583696112,"version":"3.49.0"},"reference-count":86,"publisher":"Springer Science and Business Media LLC","issue":"2-3","license":[{"start":{"date-parts":[[2015,1,29]],"date-time":"2015-01-29T00:00:00Z","timestamp":1422489600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2015,1,29]],"date-time":"2015-01-29T00:00:00Z","timestamp":1422489600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["HORM CANC"],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1007\/s12672-014-0215-9","type":"journal-article","created":{"date-parts":[[2015,1,28]],"date-time":"2015-01-28T14:57:18Z","timestamp":1422457038000},"page":"67-86","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Interaction of the Androgen Receptor, ETV1, and PTEN Pathways in Mouse Prostate Varies with Pathological Stage and Predicts Cancer Progression"],"prefix":"10.1007","volume":"6","author":[{"given":"Jake","family":"Higgins","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michele","family":"Brogley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nallasivam","family":"Palanisamy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rohit","family":"Mehra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael M.","family":"Ittmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun Z.","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Scott A.","family":"Tomlins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diane M.","family":"Robins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,1,29]]},"reference":[{"issue":"14","key":"215_CR1","first-page":"3886","volume":"63","author":"C Abate-Shen","year":"2003","unstructured":"Abate-Shen C, Banach-Petrosky WA, Sun X, Economides KD, Desai N, Gregg JP, Borowsky AD, Cardiff RD, Shen MM (2003) Nkx3.1; Pten mutant mice develop invasive prostate adenocarcinoma and lymph node metastases. Cancer Res 63(14):3886\u20133890","journal-title":"Cancer Res"},{"issue":"19","key":"215_CR2","doi-asserted-by":"publisher","first-page":"2410","DOI":"10.1101\/gad.819500","volume":"14","author":"C Abate-Shen","year":"2000","unstructured":"Abate-Shen C, Shen MM (2000) Molecular genetics of prostate cancer. Genes Dev 14(19):2410\u20132434","journal-title":"Genes Dev"},{"issue":"1","key":"215_CR3","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1093\/hmg\/ddm287","volume":"17","author":"MA Albertelli","year":"2008","unstructured":"Albertelli MA, O\u2019Mahony OA, Brogley M, Tosoian J, Steinkamp M, Daignault S, Wojno K, Robins DM (2008) Glutamine tract length of human androgen receptors affects hormone-dependent and -independent prostate cancer in mice. Hum Mol Genet 17(1):98\u2013110. doi:10.1093\/hmg\/ddm287","journal-title":"Hum Mol Genet"},{"issue":"6","key":"215_CR4","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1210\/me.2006-0021","volume":"20","author":"MA Albertelli","year":"2006","unstructured":"Albertelli MA, Scheller A, Brogley M, Robins DM (2006) Replacing the mouse androgen receptor with human alleles demonstrates glutamine tract length-dependent effects on physiology and tumorigenesis in mice. Mol Endocrinol 20(6):1248\u20131260. doi:10.1210\/me.2006-0021","journal-title":"Mol Endocrinol"},{"issue":"5","key":"215_CR5","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1038\/ng.556","volume":"42","author":"A Alimonti","year":"2010","unstructured":"Alimonti A, Carracedo A, Clohessy JG, Trotman LC, Nardella C, Egia A, Salmena L et al (2010) Subtle variations in Pten dose determine cancer susceptibility. Nat Genet 42(5):454\u2013458. doi:10.1038\/ng.556","journal-title":"Nat Genet"},{"issue":"9","key":"215_CR6","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1038\/nprot.2013.099","volume":"8","author":"S Anders","year":"2013","unstructured":"Anders S, McCarthy DJ, Chen Y, Okoniewski M, Smyth GK, Huber W, Robinson MD (2013) Count-based differential expression analysis of RNA sequencing data using R and Bioconductor. Nat Protoc 8(9):1765\u20131786. doi:10.1038\/nprot.2013.099","journal-title":"Nat Protoc"},{"issue":"12","key":"215_CR7","doi-asserted-by":"publisher","first-page":"4937","DOI":"10.1158\/0008-5472.CAN-08-4531","volume":"69","author":"G Attard","year":"2009","unstructured":"Attard G, Reid AH, Olmos D, de Bono JS (2009) Antitumor activity with CYP17 blockade indicates that castration-resistant prostate cancer frequently remains hormone driven. Cancer Res 69(12):4937\u20134940. doi:10.1158\/0008-5472.CAN-08-4531","journal-title":"Cancer Res"},{"issue":"6","key":"215_CR8","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1101\/gad.211011.112","volume":"27","author":"E Baena","year":"2013","unstructured":"Baena E, Shao Z, Linn DE, Glass K, Hamblen MJ, Fujiwara Y, Kim J et al (2013) ETV1 directs androgen metabolism and confers aggressive prostate cancer in targeted mice and patients. Genes Dev 27(6):683\u2013698. doi:10.1101\/gad.211011.112","journal-title":"Genes Dev"},{"issue":"23","key":"215_CR9","doi-asserted-by":"publisher","first-page":"9544","DOI":"10.1158\/0008-5472.CAN-10-1638","volume":"70","author":"NC Bastus","year":"2010","unstructured":"Bastus NC, Boyd LK, Mao X, Stankiewicz E, Kudahetti SC, Oliver RT, Berney DM, Lu YJ (2010) Androgen-induced TMPRSS2:ERG fusion in nonmalignant prostate epithelial cells. Cancer Res 70(23):9544\u20139548. doi:10.1158\/0008-5472.CAN-10-1638","journal-title":"Cancer Res"},{"issue":"3","key":"215_CR10","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1593\/neo.07976","volume":"10","author":"LA Begley","year":"2008","unstructured":"Begley LA, Kasina S, Mehra R, Adsule S, Admon AJ, Lonigro RJ, Chinnaiyan AM, Macoska JA (2008) CXCL5 promotes prostate cancer progression. Neoplasia 10(3):244\u2013254","journal-title":"Neoplasia"},{"issue":"43","key":"215_CR11","doi-asserted-by":"publisher","first-page":"36442","DOI":"10.1074\/jbc.M504945200","volume":"280","author":"IM Berquin","year":"2005","unstructured":"Berquin IM, Min Y, Wu R, Wu H, Chen YQ (2005) Expression signature of the mouse prostate. J Biol Chem 280(43):36442\u201336451. doi:10.1074\/jbc.M504945200","journal-title":"J Biol Chem"},{"issue":"9","key":"215_CR12","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1002\/pros.20411","volume":"66","author":"J Bertram","year":"2006","unstructured":"Bertram J, Peacock JW, Fazli L, Mui AL, Chung SW, Cox ME, Monia B, Gleave ME, Ong CJ (2006) Loss of PTEN is associated with progression to androgen independence. Prostate 66(9):895\u2013902. doi:10.1002\/pros.20411","journal-title":"Prostate"},{"key":"215_CR13","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.2012.234","author":"R Bhalla","year":"2013","unstructured":"Bhalla R, Kunju LP, Tomlins SA, Christopherson K, Cortez C, Carskadon S, Siddiqui J et al (2013) Novel dual-color immunohistochemical methods for detecting ERG-PTEN and ERG-SPINK1 status in prostate carcinoma. Mod Pathol. doi:10.1038\/modpathol.2012.234","journal-title":"Mod Pathol"},{"issue":"3","key":"215_CR14","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1111\/j.1464-410X.2010.09470.x","volume":"107","author":"TA Bismar","year":"2011","unstructured":"Bismar TA, Yoshimoto M, Vollmer RT, Duan Q, Firszt M, Corcos J, Squire JA (2011) PTEN genomic deletion is an early event associated with ERG gene rearrangements in prostate cancer. BJU Int 107(3):477\u2013485. doi:10.1111\/j.1464-410X.2010.09470.x","journal-title":"BJU Int"},{"issue":"5","key":"215_CR15","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/j.ccr.2011.04.008","volume":"19","author":"BS Carver","year":"2011","unstructured":"Carver BS, Chapinski C, Wongvipat J, Hieronymus H, Chen Y, Chandarlapaty S, Arora VK et al (2011) Reciprocal feedback regulation of PI3K and androgen receptor signaling in PTEN-deficient prostate cancer. Cancer Cell 19(5):575\u2013586. doi:10.1016\/j.ccr.2011.04.008","journal-title":"Cancer Cell"},{"issue":"5","key":"215_CR16","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1038\/ng.370","volume":"41","author":"BS Carver","year":"2009","unstructured":"Carver BS, Tran J, Gopalan A, Chen Z, Shaikh S, Carracedo A, Alimonti A et al (2009) Aberrant ERG expression cooperates with loss of PTEN to promote cancer progression in the prostate. Nat Genet 41(5):619\u2013624. doi:10.1038\/ng.370","journal-title":"Nat Genet"},{"issue":"15","key":"215_CR17","doi-asserted-by":"publisher","first-page":"3181","DOI":"10.1093\/nar\/22.15.3181","volume":"22","author":"NL Chamberlain","year":"1994","unstructured":"Chamberlain NL, Driver ED, Miesfeld RL (1994) The length and location of CAG trinucleotide repeats in the androgen receptor N-terminal domain affect transactivation function. Nucleic Acids Res 22(15):3181\u20133186","journal-title":"Nucleic Acids Res"},{"key":"215_CR18","doi-asserted-by":"publisher","DOI":"10.1038\/nm.3216","author":"Y Chen","year":"2013","unstructured":"Chen Y, Chi P, Rockowitz S, Iaquinta PJ, Shamu T, Shukla S, Gao D et al (2013) ETS factors reprogram the androgen receptor cistrome and prime prostate tumorigenesis in response to PTEN loss. Nat Med. doi:10.1038\/nm.3216","journal-title":"Nat Med"},{"issue":"1","key":"215_CR19","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1186\/1471-2407-12-543","volume":"12","author":"K Choucair","year":"2012","unstructured":"Choucair K, Ejdelman J, Brimo F, Aprikian A, Chevalier S, Lapointe J (2012) PTEN genomic deletion predicts prostate cancer recurrence and is associated with low AR expression and transcriptional activity. BMC Cancer 12(1):543. doi:10.1186\/1471-2407-12-543","journal-title":"BMC Cancer"},{"issue":"1","key":"215_CR20","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/nprot.2008.211","volume":"4","author":"W da Huangda","year":"2009","unstructured":"da Huangda W, Sherman BT, Lempicki RA (2009) Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 4(1):44\u201357. doi:10.1038\/nprot.2008.211","journal-title":"Nat Protoc"},{"key":"215_CR21","doi-asserted-by":"crossref","unstructured":"DePrimo, S. E., M. Diehn, J. B. Nelson, R. E. Reiter, J. Matese, M. Fero, R. Tibshirani, P. O. Brown, and J. D. Brooks (2002) Transcriptional programs activated by exposure of human prostate cancer cells to androgen. Genome Biol 3 (7):RESEARCH0032","DOI":"10.1186\/gb-2002-3-7-research0032"},{"issue":"11","key":"215_CR22","doi-asserted-by":"publisher","first-page":"e81702","DOI":"10.1371\/journal.pone.0081702","volume":"8","author":"B Dun","year":"2013","unstructured":"Dun B, Sharma A, Teng Y, Liu H, Purohit S, Xu H, Zeng L, She JX (2013) Mycophenolic acid inhibits migration and invasion of gastric cancer cells via multiple molecular pathways. PLoS One 8(11):e81702. doi:10.1371\/journal.pone.0081702","journal-title":"PLoS One"},{"issue":"8","key":"215_CR23","doi-asserted-by":"publisher","first-page":"1484","DOI":"10.1210\/me.2003-0020","volume":"17","author":"N Gao","year":"2003","unstructured":"Gao N, Zhang J, Rao MA, Case TC, Mirosevich J, Wang Y, Jin R, Gupta A, Rennie PS, Matusik RJ (2003) The role of hepatocyte nuclear factor-3 alpha (Forkhead Box A1) and androgen receptor in transcriptional regulation of prostatic genes. Mol Endocrinol 17(8):1484\u20131507. doi:10.1210\/me.2003-0020","journal-title":"Mol Endocrinol"},{"issue":"4","key":"215_CR24","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1093\/hmg\/ddi043","volume":"14","author":"C Garnis","year":"2005","unstructured":"Garnis C, Campbell J, Davies JJ, Macaulay C, Lam S, Lam WL (2005) Involvement of multiple developmental genes on chromosome 1p in lung tumorigenesis. Hum Mol Genet 14(4):475\u2013482. doi:10.1093\/hmg\/ddi043","journal-title":"Hum Mol Genet"},{"key":"215_CR25","doi-asserted-by":"publisher","DOI":"10.1038\/nature11125","author":"CS Grasso","year":"2012","unstructured":"Grasso CS, Wu YM, Robinson DR, Cao X, Dhanasekaran SM, Khan AP, Quist MJ et al (2012) The mutational landscape of lethal castration-resistant prostate cancer. Nature. doi:10.1038\/nature11125","journal-title":"Nature"},{"key":"215_CR26","doi-asserted-by":"publisher","DOI":"10.1038\/pcan.2013.8","author":"B Gumuskaya","year":"2013","unstructured":"Gumuskaya B, Gurel B, Fedor H, Tan HL, Weier CA, Hicks JL, Haffner MC, Lotan TL, De Marzo AM (2013) Assessing the order of critical alterations in prostate cancer development and progression by IHC: further evidence that PTEN loss occurs subsequent to ERG gene fusion. Prostate Cancer Prostatic Dis. doi:10.1038\/pcan.2013.8","journal-title":"Prostate Cancer Prostatic Dis"},{"issue":"12","key":"215_CR27","doi-asserted-by":"publisher","first-page":"2114","DOI":"10.1002\/ar.22571","volume":"295","author":"X Guo","year":"2012","unstructured":"Guo X, Wang W, Hu J, Feng K, Pan Y, Zhang L, Feng Y (2012) Lentivirus-mediated RNAi knockdown of NUPR1 inhibits human nonsmall cell lung cancer growth in vitro and in vivo. Anat Rec (Hoboken) 295(12):2114\u20132121. doi:10.1002\/ar.22571","journal-title":"Anat Rec (Hoboken)"},{"issue":"6","key":"215_CR28","doi-asserted-by":"publisher","first-page":"2092","DOI":"10.1172\/JCI60144","volume":"122","author":"T Hamidi","year":"2012","unstructured":"Hamidi T, Algul H, Cano CE, Sandi MJ, Molejon MI, Riemann M, Calvo EL et al (2012) Nuclear protein 1 promotes pancreatic cancer development and protects cells from stress by inhibiting apoptosis. J Clin Invest 122(6):2092\u20132103. doi:10.1172\/JCI60144","journal-title":"J Clin Invest"},{"issue":"20","key":"215_CR29","doi-asserted-by":"publisher","first-page":"2147","DOI":"10.1101\/gad.17546311","volume":"25","author":"PC Hollenhorst","year":"2011","unstructured":"Hollenhorst PC, Ferris MW, Hull MA, Chae H, Kim S, Graves BJ (2011) Oncogenic ETS proteins mimic activated RAS\/MAPK signaling in prostate cells. Genes Dev 25(20):2147\u20132157. doi:10.1101\/gad.17546311","journal-title":"Genes Dev"},{"issue":"1","key":"215_CR30","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/S0002-9440(10)63112-4","volume":"164","author":"J Holzbeierlein","year":"2004","unstructured":"Holzbeierlein J, Lal P, LaTulippe E, Smith A, Satagopan J, Zhang L, Ryan C et al (2004) Gene expression analysis of human prostate carcinoma during hormonal therapy identifies androgen-responsive genes and mechanisms of therapy resistance. Am J Pathol 164(1):217\u2013227. doi:10.1016\/S0002-9440(10)63112-4","journal-title":"Am J Pathol"},{"issue":"9","key":"215_CR31","doi-asserted-by":"publisher","first-page":"2718","DOI":"10.1158\/0008-5472.CAN-12-4213","volume":"73","author":"M Ittmann","year":"2013","unstructured":"Ittmann M, Huang J, Radaelli E, Martin P, Signoretti S, Sullivan R, Simons BW (2013) Animal models of human prostate cancer: the consensus report of the New York meeting of the Mouse Models of Human Cancers Consortium Prostate Pathology Committee. Cancer Res 73(9):2718\u20132736. doi:10.1158\/0008-5472.CAN-12-4213","journal-title":"Cancer Res"},{"issue":"4","key":"215_CR32","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1002\/pros.20148","volume":"62","author":"MA Johnson","year":"2005","unstructured":"Johnson MA, Iversen P, Schwier P, Corn AL, Sandusky G, Graff J, Neubauer BL (2005) Castration triggers growth of previously static androgen-independent lesions in the transgenic adenocarcinoma of the mouse prostate (TRAMP) model. Prostate 62(4):322\u2013338. doi:10.1002\/pros.20148","journal-title":"Prostate"},{"issue":"3","key":"215_CR33","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1158\/1055-9965.EPI-04-0398","volume":"14","author":"SB Jones","year":"2005","unstructured":"Jones SB, DePrimo SE, Whitfield ML, Brooks JD (2005) Resveratrol-induced gene expression profiles in human prostate cancer cells. Cancer Epidemiol Biomarkers Prev 14(3):596\u2013604. doi:10.1158\/1055-9965.EPI-04-0398","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"215_CR34","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.1038\/ncomms2766","volume":"4","author":"Y Jung","year":"2013","unstructured":"Jung Y, Kim JK, Shiozawa Y, Wang J, Mishra A, Joseph J, Berry JE et al (2013) Recruitment of mesenchymal stem cells into prostate tumours promotes metastasis. Nat Commun 4:1795. doi:10.1038\/ncomms2766","journal-title":"Nat Commun"},{"key":"215_CR35","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1186\/1471-2407-12-382","volume":"12","author":"SH Jung","year":"2012","unstructured":"Jung SH, Lee A, Yim SH, Hu HJ, Choe C, Chung YJ (2012) Simultaneous copy number gains of NUPR1 and ERBB2 predicting poor prognosis in early-stage breast cancer. BMC Cancer 12:382. doi:10.1186\/1471-2407-12-382","journal-title":"BMC Cancer"},{"issue":"1","key":"215_CR36","first-page":"205","volume":"35","author":"H Kang","year":"2009","unstructured":"Kang H, Escudero-Esparza A, Douglas-Jones A, Mansel RE, Jiang WG (2009) Transcript analyses of stromal cell derived factors (SDFs): SDF-2, SDF-4 and SDF-5 reveal a different pattern of expression and prognostic association in human breast cancer. Int J Oncol 35(1):205\u2013211","journal-title":"Int J Oncol"},{"issue":"11","key":"215_CR37","first-page":"2999","volume":"62","author":"MJ Kim","year":"2002","unstructured":"Kim MJ, Bhatia-Gaur R, Banach-Petrosky WA, Desai N, Wang Y, Hayward SW, Cunha GR, Cardiff RD, Shen MM, Abate-Shen C (2002) Nkx3.1 mutant mice recapitulate early stages of prostate carcinogenesis. Cancer Res 62(11):2999\u20133004","journal-title":"Cancer Res"},{"issue":"4","key":"215_CR38","doi-asserted-by":"publisher","first-page":"R36","DOI":"10.1186\/gb-2013-14-4-r36","volume":"14","author":"D Kim","year":"2013","unstructured":"Kim D, Pertea G, Trapnell C, Pimentel H, Kelley R, Salzberg SL (2013) TopHat2: accurate alignment of transcriptomes in the presence of insertions, deletions and gene fusions. Genome Biol 14(4):R36. doi:10.1186\/gb-2013-14-4-r36","journal-title":"Genome Biol"},{"issue":"5","key":"215_CR39","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1038\/ng.371","volume":"41","author":"JC King","year":"2009","unstructured":"King JC, Xu J, Wongvipat J, Hieronymus H, Carver BS, Leung DH, Taylor BS et al (2009) Cooperativity of TMPRSS2-ERG with PI3-kinase pathway activation in prostate oncogenesis. Nat Genet 41(5):524\u2013526. doi:10.1038\/ng.371","journal-title":"Nat Genet"},{"key":"215_CR40","doi-asserted-by":"crossref","unstructured":"Knudsen, K. E., and W.K. Kelly (2011) Outsmarting androgen receptor: creative approaches for targeting aberrant androgen signaling in advances prostate cancer","DOI":"10.1586\/eem.11.33"},{"issue":"8","key":"215_CR41","doi-asserted-by":"publisher","first-page":"e32","DOI":"10.1097\/PAI.0000000000000095","volume":"22","author":"LP Kunju","year":"2014","unstructured":"Kunju LP, Carskadon S, Siddiqui J, Tomlins SA, Chinnaiyan AM, Palanisamy N (2014) Novel RNA hybridization method for the in situ detection of ETV1, ETV4, and ETV5 gene fusions in prostate cancer. Appl Immunohistochem Mol Morphol 22(8):e32\u2013e40. doi:10.1097\/PAI.0000000000000095","journal-title":"Appl Immunohistochem Mol Morphol"},{"issue":"3","key":"215_CR42","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1073\/pnas.0304146101","volume":"101","author":"J Lapointe","year":"2004","unstructured":"Lapointe J, Li C, Higgins JP, van de Rijn M, Bair E, Montgomery K, Ferrari M et al (2004) Gene expression profiling identifies clinically relevant subtypes of prostate cancer. Proc Natl Acad Sci U S A 101(3):811\u2013816. doi:10.1073\/pnas.0304146101","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"215_CR43","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1002\/gene.10036","volume":"32","author":"R Lesche","year":"2002","unstructured":"Lesche R, Groszer M, Gao J, Wang Y, Messing A, Sun H, Liu X, Wu H (2002) Cre\/loxP-mediated inactivation of the murine Pten tumor suppressor gene. Genesis 32(2):148\u2013149. doi:10.1002\/gene.10036","journal-title":"Genesis"},{"issue":"22","key":"215_CR44","doi-asserted-by":"publisher","first-page":"11077","DOI":"10.1158\/0008-5472.CAN-06-3024","volume":"66","author":"S Lindstrom","year":"2006","unstructured":"Lindstrom S, Wiklund F, Adami HO, Balter KA, Adolfsson J, Gronberg H (2006) Germ-line genetic variation in the key androgen-regulating genes androgen receptor, cytochrome P450, and steroid-5-alpha-reductase type 2 is important for prostate cancer development. Cancer Res 66(22):11077\u201311083. doi:10.1158\/0008-5472.CAN-06-3024","journal-title":"Cancer Res"},{"issue":"16","key":"215_CR45","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1002\/pros.20489","volume":"66","author":"S Lindstrom","year":"2006","unstructured":"Lindstrom S, Zheng SL, Wiklund F, Jonsson BA, Adami HO, Balter KA, Brookes AJ et al (2006) Systematic replication study of reported genetic associations in prostate cancer: strong support for genetic variation in the androgen pathway. Prostate 66(16):1729\u20131743. doi:10.1002\/pros.20489","journal-title":"Prostate"},{"issue":"5556","key":"215_CR46","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1126\/science.1067081","volume":"295","author":"C Lois","year":"2002","unstructured":"Lois C, Hong EJ, Pease S, Brown EJ, Baltimore D (2002) Germline transmission and tissue-specific expression of transgenes delivered by lentiviral vectors. Science 295(5556):868\u2013872. doi:10.1126\/science.1067081","journal-title":"Science"},{"issue":"2","key":"215_CR47","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1677\/ERC-09-0038","volume":"16","author":"M Lupien","year":"2009","unstructured":"Lupien M, Brown M (2009) Cistromics of hormone-dependent cancer. Endocr Relat Cancer 16(2):381\u2013389. doi:10.1677\/ERC-09-0038","journal-title":"Endocr Relat Cancer"},{"issue":"17","key":"215_CR48","doi-asserted-by":"publisher","first-page":"7991","DOI":"10.1158\/0008-5472.CAN-07-2043","volume":"67","author":"R Mehra","year":"2007","unstructured":"Mehra R, Han B, Tomlins SA, Wang L, Menon A, Wasco MJ, Shen R, Montie JE, Chinnaiyan AM, Shah RB (2007) Heterogeneity of TMPRSS2 gene rearrangements in multifocal prostate adenocarcinoma: molecular evidence for an independent group of diseases. Cancer Res 67(17):7991\u20137995. doi:10.1158\/0008-5472.CAN-07-2043","journal-title":"Cancer Res"},{"key":"215_CR49","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2014.308","author":"Z Mounir","year":"2014","unstructured":"Mounir Z, Lin F, Lin VG, Korn JM, Yu Y, Valdez R, Aina OH et al (2014) TMPRSS2:ERG blocks neuroendocrine and luminal cell differentiation to maintain prostate cancer proliferation. Oncogene. doi:10.1038\/onc.2014.308","journal-title":"Oncogene"},{"key":"215_CR50","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2011.05.006","author":"DJ Mulholland","year":"2011","unstructured":"Mulholland DJ, Tran LM, Li Y, Cai H, Morim A, Wang S, Plaisier S et al (2011) Cell autonomous role of PTEN in regulating castration-resistant prostate cancer growth. Cancer Cell. doi:10.1016\/j.ccr.2011.05.006","journal-title":"Cancer Cell"},{"issue":"5","key":"215_CR51","doi-asserted-by":"publisher","first-page":"e2318","DOI":"10.1371\/journal.pone.0002318","volume":"3","author":"T Nakagawa","year":"2008","unstructured":"Nakagawa T, Kollmeyer TM, Morlan BW, Anderson SK, Bergstralh EJ, Davis BJ, Asmann YW, Klee GG, Ballman KV, Jenkins RB (2008) A tissue biomarker panel predicting systemic progression after PSA recurrence post-definitive prostate cancer therapy. PLoS One 3(5):e2318. doi:10.1371\/journal.pone.0002318","journal-title":"PLoS One"},{"issue":"1","key":"215_CR52","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1254\/jphs.08208SC","volume":"109","author":"S Ohya","year":"2009","unstructured":"Ohya S, Kimura K, Niwa S, Ohno A, Kojima Y, Sasaki S, Kohri K, Imaizumi Y (2009) Malignancy grade-dependent expression of K+\u2212channel subtypes in human prostate cancer. J Pharmacol Sci 109(1):148\u2013151","journal-title":"J Pharmacol Sci"},{"issue":"2","key":"215_CR53","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1124\/jpet.111.182782","volume":"338","author":"S Ohya","year":"2011","unstructured":"Ohya S, Niwa S, Kojima Y, Sasaki S, Sakuragi M, Kohri K, Imaizumi Y (2011) Intermediate-conductance Ca2+\u2212activated K+ channel, KCa3.1, as a novel therapeutic target for benign prostatic hyperplasia. J Pharmacol Exp Ther 338(2):528\u2013536. doi:10.1124\/jpet.111.182782","journal-title":"J Pharmacol Exp Ther"},{"issue":"3","key":"215_CR54","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1136\/gut.2011.241034","volume":"61","author":"Y Okamoto","year":"2012","unstructured":"Okamoto Y, Sawaki A, Ito S, Nishida T, Takahashi T, Toyota M, Suzuki H et al (2012) Aberrant DNA methylation associated with aggressiveness of gastrointestinal stromal tumour. Gut 61(3):392\u2013401. doi:10.1136\/gut.2011.241034","journal-title":"Gut"},{"issue":"2","key":"215_CR55","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1016\/S0002-9440(10)64228-9","volume":"161","author":"JH Park","year":"2002","unstructured":"Park JH, Walls JE, Galvez JJ, Kim M, Abate-Shen C, Shen MM, Cardiff RD (2002) Prostatic intraepithelial neoplasia in genetically engineered mice. Am J Pathol 161(2):727\u2013735. doi:10.1016\/S0002-9440(10)64228-9","journal-title":"Am J Pathol"},{"issue":"5","key":"215_CR56","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1016\/j.cell.2012.10.028","volume":"151","author":"N Pencheva","year":"2012","unstructured":"Pencheva N, Tran H, Buss C, Huh D, Drobnjak M, Busam K, Tavazoie SF (2012) Convergent multi-miRNA targeting of ApoE drives LRP1\/LRP8-dependent melanoma metastasis and angiogenesis. Cell 151(5):1068\u20131082. doi:10.1016\/j.cell.2012.10.028","journal-title":"Cell"},{"issue":"1","key":"215_CR57","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1073\/pnas.232688199","volume":"100","author":"XF Qin","year":"2003","unstructured":"Qin XF, An DS, Chen IS, Baltimore D (2003) Inhibiting HIV-1 infection in human T cells by lentiviral-mediated delivery of small interfering RNA against CCR5. Proc Natl Acad Sci U S A 100(1):183\u2013188. doi:10.1073\/pnas.232688199","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"215_CR58","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1593\/neo.07292","volume":"9","author":"DR Rhodes","year":"2007","unstructured":"Rhodes DR, Kalyana-Sundaram S, Tomlins SA, Mahavisno V, Kasper N, Varambally R, Barrette TR, Ghosh D, Varambally S, Chinnaiyan AM (2007) Molecular concepts analysis links tumors, pathways, mechanisms, and drugs. Neoplasia 9(5):443\u2013454","journal-title":"Neoplasia"},{"issue":"1","key":"215_CR59","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S1476-5586(04)80047-2","volume":"6","author":"DR Rhodes","year":"2004","unstructured":"Rhodes DR, Yu J, Shanker K, Deshpande N, Varambally R, Ghosh D, Barrette T, Pandey A, Chinnaiyan AM (2004) ONCOMINE: a cancer microarray database and integrated data-mining platform. Neoplasia 6(1):1\u20136","journal-title":"Neoplasia"},{"issue":"27","key":"215_CR60","doi-asserted-by":"publisher","first-page":"3659","DOI":"10.1200\/JCO.2011.35.1916","volume":"29","author":"MA Rubin","year":"2011","unstructured":"Rubin MA, Maher CA, Chinnaiyan AM (2011) Common gene rearrangements in prostate cancer. J Clin Oncol 29(27):3659\u20133668. doi:10.1200\/JCO.2011.35.1916","journal-title":"J Clin Oncol"},{"key":"215_CR61","doi-asserted-by":"publisher","DOI":"10.1097\/PAI.0000000000000085","author":"UG Sathyanarayana","year":"2014","unstructured":"Sathyanarayana UG, Birch C, Nagle RB, Tomlins SA, Palanisamy N, Zhang W, Hubbard A, Brunhoeber P, Wang Y, Tang L (2014) Determination of optimum formalin fixation duration for prostate needle biopsies for immunohistochemistry and quantum dot FISH analysis. Appl Immunohistochem Mol Morphol. doi:10.1097\/PAI.0000000000000085","journal-title":"Appl Immunohistochem Mol Morphol"},{"issue":"6","key":"215_CR62","doi-asserted-by":"publisher","first-page":"2270","DOI":"10.1158\/0008-5472.CAN-03-0946","volume":"64","author":"SB Shappell","year":"2004","unstructured":"Shappell SB, Thomas GV, Roberts RL, Herbert R, Ittmann MM, Rubin MA, Humphrey PA et al (2004) Prostate pathology of genetically engineered mice: definitions and classification. The consensus report from the Bar Harbor meeting of the Mouse Models of Human Cancer Consortium Prostate Pathology Committee. Cancer Res 64(6):2270\u20132305","journal-title":"Cancer Res"},{"issue":"18","key":"215_CR63","doi-asserted-by":"publisher","first-page":"1967","DOI":"10.1101\/gad.1965810","volume":"24","author":"MM Shen","year":"2010","unstructured":"Shen MM, Abate-Shen C (2010) Molecular genetics of prostate cancer: new prospects for old challenges. Genes Dev 24(18):1967\u20132000. doi:10.1101\/gad.1965810","journal-title":"Genes Dev"},{"issue":"20","key":"215_CR64","doi-asserted-by":"publisher","first-page":"8102","DOI":"10.1158\/0008-5472.CAN-09-0941","volume":"69","author":"S Shin","year":"2009","unstructured":"Shin S, Kim TD, Jin F, van Deursen JM, Dehm SM, Tindall DJ, Grande JP, Munz JM, Vasmatzis G, Janknecht R (2009) Induction of prostatic intraepithelial neoplasia and modulation of androgen receptor by ETS variant 1\/ETS-related protein 81. Cancer Res 69(20):8102\u20138110. doi:10.1158\/0008-5472.CAN-09-0941","journal-title":"Cancer Res"},{"issue":"1\u20132","key":"215_CR65","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.mce.2011.05.011","volume":"342","author":"U Simanainen","year":"2011","unstructured":"Simanainen U, Brogley M, Gao YR, Jimenez M, Harwood DT, Handelsman DJ, Robins DM (2011) Length of the human androgen receptor glutamine tract determines androgen sensitivity in vivo. Mol Cell Endocrinol 342(1\u20132):81\u201386. doi:10.1016\/j.mce.2011.05.011","journal-title":"Mol Cell Endocrinol"},{"key":"215_CR66","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajpath.2014.06.022","author":"M Singh","year":"2014","unstructured":"Singh M, Jha R, Melamed J, Shapiro E, Hayward SW, Lee P (2014) Stromal androgen receptor in prostate development and cancer. Am J Pathol. doi:10.1016\/j.ajpath.2014.06.022","journal-title":"Am J Pathol"},{"issue":"1","key":"215_CR67","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/S0092-8674(00)81780-8","volume":"95","author":"V Stambolic","year":"1998","unstructured":"Stambolic V, Suzuki A, de la Pompa JL, Brothers GM, Mirtsos C, Sasaki T, Ruland J, Penninger JM, Siderovski DP, Mak TW (1998) Negative regulation of PKB\/Akt-dependent cell survival by the tumor suppressor PTEN. Cell 95(1):29\u201339","journal-title":"Cell"},{"issue":"10","key":"215_CR68","doi-asserted-by":"publisher","first-page":"4434","DOI":"10.1158\/0008-5472.CAN-08-3605","volume":"69","author":"MP Steinkamp","year":"2009","unstructured":"Steinkamp MP, O\u2019Mahony OA, Brogley M, Rehman H, Lapensee EW, Dhanasekaran S, Hofer MD et al (2009) Treatment-dependent androgen receptor mutations in prostate cancer exploit multiple mechanisms to evade therapy. Cancer Res 69(10):4434\u20134442. doi:10.1158\/0008-5472.CAN-08-3605","journal-title":"Cancer Res"},{"issue":"2","key":"215_CR69","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.ydbio.2004.06.008","volume":"273","author":"B Stiles","year":"2004","unstructured":"Stiles B, Groszer M, Wang S, Jiao J, Wu H (2004) PTENless means more. Dev Biol 273(2):175\u2013184. doi:10.1016\/j.ydbio.2004.06.008","journal-title":"Dev Biol"},{"issue":"3","key":"215_CR70","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1038\/labinvest.2010.179","volume":"91","author":"MA Svensson","year":"2011","unstructured":"Svensson MA, LaFargue CJ, MacDonald TY, Pflueger D, Kitabayashi N, Santa-Cruz AM, Garsha KE et al (2011) Testing mutual exclusivity of ETS rearranged prostate cancer. Lab Invest 91(3):404\u2013412. doi:10.1038\/labinvest.2010.179","journal-title":"Lab Invest"},{"issue":"5","key":"215_CR71","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.18632\/oncotarget.1817","volume":"5","author":"X Tang","year":"2014","unstructured":"Tang X, Mahajan SS, Nguyen LT, Beliveau F, Leduc R, Simon JA, Vasioukhin V (2014) Targeted inhibition of cell-surface serine protease Hepsin blocks prostate cancer bone metastasis. Oncotarget 5(5):1352\u20131362","journal-title":"Oncotarget"},{"key":"215_CR72","doi-asserted-by":"publisher","DOI":"10.1002\/pros.22863","author":"M Taris","year":"2014","unstructured":"Taris M, Irani J, Blanchet P, Multigner L, Cathelineau X, Fromont G (2014) ERG expression in prostate cancer: the prognostic paradox. Prostate. doi:10.1002\/pros.22863","journal-title":"Prostate"},{"issue":"1","key":"215_CR73","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.ccr.2010.05.026","volume":"18","author":"BS Taylor","year":"2010","unstructured":"Taylor BS, Schultz N, Hieronymus H, Gopalan A, Xiao Y, Carver BS, Arora VK et al (2010) Integrative genomic profiling of human prostate cancer. Cancer Cell 18(1):11\u201322. doi:10.1016\/j.ccr.2010.05.026","journal-title":"Cancer Cell"},{"issue":"7153","key":"215_CR74","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1038\/nature06024","volume":"448","author":"SA Tomlins","year":"2007","unstructured":"Tomlins SA, Laxman B, Dhanasekaran SM, Helgeson BE, Cao X, Morris DS, Menon A et al (2007) Distinct classes of chromosomal rearrangements create oncogenic ETS gene fusions in prostate cancer. Nature 448(7153):595\u2013599. doi:10.1038\/nature06024","journal-title":"Nature"},{"issue":"2","key":"215_CR75","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1593\/neo.07822","volume":"10","author":"SA Tomlins","year":"2008","unstructured":"Tomlins SA, Laxman B, Varambally S, Cao X, Yu J, Helgeson BE, Cao Q et al (2008) Role of the TMPRSS2-ERG gene fusion in prostate cancer. Neoplasia 10(2):177\u2013188","journal-title":"Neoplasia"},{"issue":"5748","key":"215_CR76","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1126\/science.1117679","volume":"310","author":"SA Tomlins","year":"2005","unstructured":"Tomlins SA, Rhodes DR, Perner S, Dhanasekaran SM, Mehra R, Sun XW, Varambally S et al (2005) Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer. Science 310(5748):644\u2013648. doi:10.1126\/science.1117679","journal-title":"Science"},{"issue":"3","key":"215_CR77","doi-asserted-by":"publisher","first-page":"E59","DOI":"10.1371\/journal.pbio.0000059","volume":"1","author":"LC Trotman","year":"2003","unstructured":"Trotman LC, Niki M, Dotan ZA, Koutcher JA, Di Cristofano A, Xiao A, Khoo AS et al (2003) Pten dose dictates cancer progression in the prostate. PLoS Biol 1(3):E59. doi:10.1371\/journal.pbio.0000059","journal-title":"PLoS Biol"},{"issue":"7263","key":"215_CR78","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1038\/nature08361","volume":"461","author":"X Wang","year":"2009","unstructured":"Wang X, Kruithof-de Julio M, Economides KD, Walker D, Yu H, Halili MV, Hu YP, Price SM, Abate-Shen C, Shen MM (2009) A luminal epithelial stem cell that is a cell of origin for prostate cancer. Nature 461(7263):495\u2013500. doi:10.1038\/nature08361","journal-title":"Nature"},{"key":"215_CR79","doi-asserted-by":"publisher","DOI":"10.1002\/pros.22783","author":"L Wang","year":"2014","unstructured":"Wang L, Li Y, Yang X, Yuan H, Li X, Qi M, Chang YW et al (2014) ERG-SOX4 interaction promotes epithelial-mesenchymal transition in prostate cancer cells. Prostate. doi:10.1002\/pros.22783","journal-title":"Prostate"},{"issue":"88","key":"215_CR80","first-page":"2039","volume":"55","author":"X Wang","year":"2008","unstructured":"Wang X, Zbou C, Qiu G, Fan J, Tang H, Peng Z (2008) Screening of new tumor suppressor genes in sporadic colorectal cancer patients. Hepatogastroenterology 55(88):2039\u20132044","journal-title":"Hepatogastroenterology"},{"issue":"9","key":"215_CR81","doi-asserted-by":"publisher","first-page":"5246","DOI":"10.1073\/pnas.95.9.5246","volume":"95","author":"YE Whang","year":"1998","unstructured":"Whang YE, Wu X, Suzuki H, Reiter RE, Tran C, Vessella RL, Said JW, Isaacs WB, Sawyers CL (1998) Inactivation of the tumor suppressor PTEN\/MMAC1 in advanced human prostate cancer through loss of expression. Proc Natl Acad Sci U S A 95(9):5246\u20135250","journal-title":"Proc Natl Acad Sci U S A"},{"key":"215_CR82","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-14-0020","author":"S Yoo","year":"2014","unstructured":"Yoo S, Pettersson A, Jordahl KM, Lis RT, Lindstrom S, Meisner A, Nuttall EJ et al (2014) Androgen receptor CAG repeat polymorphism and risk of TMPRSS2:ERG positive prostate cancer. Cancer Epidemiol Biomarkers Prev. doi:10.1158\/1055-9965.EPI-14-0020","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"215_CR83","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/2047-783X-18-56","volume":"18","author":"S Yu","year":"2013","unstructured":"Yu S, Feng F, Wang K, Men C, Lin C, Liu Q, Yang D, Gao Z (2013) The therapeutic efficacy of I131-PSCA-mAb in orthotopic mouse models of prostate cancer. Eur J Med Res 18:56. doi:10.1186\/2047-783X-18-56","journal-title":"Eur J Med Res"},{"issue":"14","key":"215_CR84","doi-asserted-by":"publisher","first-page":"2790","DOI":"10.1200\/JCO.2004.05.158","volume":"22","author":"YP Yu","year":"2004","unstructured":"Yu YP, Landsittel D, Jing L, Nelson J, Ren B, Liu L, McDonald C et al (2004) Gene expression alterations in prostate cancer predicting tumor aggression and preceding development of malignancy. J Clin Oncol 22(14):2790\u20132799. doi:10.1200\/JCO.2004.05.158","journal-title":"J Clin Oncol"},{"issue":"5","key":"215_CR85","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/j.ccr.2010.03.018","volume":"17","author":"J Yu","year":"2010","unstructured":"Yu J, Mani RS, Cao Q, Brenner CJ, Cao X, Wang X, Wu L et al (2010) An integrated network of androgen receptor, polycomb, and TMPRSS2-ERG gene fusions in prostate cancer progression. Cancer Cell 17(5):443\u2013454. doi:10.1016\/j.ccr.2010.03.018","journal-title":"Cancer Cell"},{"issue":"16","key":"215_CR86","doi-asserted-by":"publisher","first-page":"3766","DOI":"10.1111\/febs.12902","volume":"281","author":"M Zhu","year":"2014","unstructured":"Zhu M, Chen Q, Liu X, Sun Q, Zhao X, Deng R, Wang Y et al (2014) lncRNA H19\/miR-675 axis represses prostate cancer metastasis by targeting TGFBI. FEBS J 281(16):3766\u20133775. doi:10.1111\/febs.12902","journal-title":"FEBS J"}],"container-title":["Hormones and Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-014-0215-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12672-014-0215-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-014-0215-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-014-0215-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,6]],"date-time":"2024-06-06T21:41:22Z","timestamp":1717710082000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12672-014-0215-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1,29]]},"references-count":86,"journal-issue":{"issue":"2-3","published-print":{"date-parts":[[2015,6]]}},"alternative-id":["215"],"URL":"https:\/\/doi.org\/10.1007\/s12672-014-0215-9","relation":{},"ISSN":["1868-8497","1868-8500"],"issn-type":[{"value":"1868-8497","type":"print"},{"value":"1868-8500","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,1,29]]},"assertion":[{"value":"3 December 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 December 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 January 2015","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}